Left Ventricular Dysfunction Clinical Trials
2 recruiting trials for Left Ventricular Dysfunction. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Left Ventricular Dysfunction clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Azienda Ospedaliera Universitaria Integrata Verona (1), Herlev and Gentofte Hospital (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Thermodilution based assessment of coronary microcirculation (diagnostic_test, 1 trial).
Track Left Ventricular Dysfunction trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remodeling
Patients presenting with idiopathic dilated cardiomyopathy and left ventricle dysfunction (LVEF \<40%), naive of anti-remodeling cardiac medical therapy, will undergo invasive...
Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis
In a prospective cohort study (n = 1.000), the investigators aim to investigate the correlation between cardiac biomarkers and advanced echocardiography and determine whether...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Left Ventricular Dysfunction, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Left Ventricular Dysfunction, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Left Ventricular Dysfunction, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.